Search

Our study provides evidence that OT-82 is a promising new therapeutic strategy for a broad spectrum of high-risk pediatric acute lymphoblastic leukemia

The largest GWAS meta-analysis conducted to date associating SNPs to venous thromboembolism in children and adolescents treated on childhood ALL protocols

The aim of our study was to investigate whether CBL0137 has potential as a therapeutic and chemopotentiating compound in MLL-r leukemia

Our approach to hematopoietic progenitor cells mobilization resulted in highly effective HPC harvest in children and adolescents with high-risk cancers

Children with Primary Central Nervous System Lymphoma and no immunodeficiency have a good outcome

Invasive fungal infections are more common in children with high-risk acute lymphoblastic leukaemia and in relapsed disease

This study thus identified a novel small molecule that rapidly kills MLL-rearranged leukemia cells by targeting a metabolic vulnerability

There is a high incidence of vaccine-preventable morbidity post-allogeneic haematopoietic stem cell transplantation in West Australian children

We conclude that the novel chocolate-based formulation of midazolam provides improved tolerability while remaining efficacious

We provide evidence that targeting leukemia-induced bone loss is a therapeutic strategy for pre-B ALL